Product Overview: Levemir Novo Nordisk
Levemir Novo Nordisk is a long-acting insulin analogue specifically engineered for in-vitro metabolic research applications. This pharmaceutical-grade compound represents one of the most advanced insulin formulations available to researchers investigating glucose homeostasis, insulin signaling pathways, and diabetic disease models. As a leading supplier in the UK, Stroid UK Shop provides this research-grade insulin analogue to support cutting-edge laboratory studies examining metabolic dysfunction and therapeutic intervention strategies.
The compound features a unique molecular structure that enables extended duration of action compared to traditional insulin preparations, making it particularly valuable for studies requiring sustained metabolic modulation. Research scientists examine this insulin analogue to understand its pharmacokinetic properties, receptor binding characteristics, and metabolic effects in various experimental models. The formulation’s consistency and reliability make it essential for reproducible research outcomes across multiple laboratory settings.
Laboratory Applications
Research applications for this insulin analogue encompass multiple areas of metabolic science and endocrinology research. Scientists investigate its effects on glucose uptake mechanisms in cell culture studies, examining how different concentrations influence cellular metabolism and insulin receptor signaling cascades. The compound serves as a valuable tool for researchers studying diabetes mellitus pathophysiology, allowing detailed analysis of insulin resistance mechanisms and potential therapeutic targets.
Comparative studies often utilize this insulin preparation alongside other metabolic modulators available through our general health insulin category, enabling comprehensive metabolic research protocols. Additionally, researchers examining peptide-based therapeutics from our peptides collection and selective modulators from our SARMs range incorporate this insulin analogue to study metabolic interactions and cellular energy pathways in controlled laboratory environments.
Compound Specifications
| Parameter | Specification |
|---|---|
| Product Name | Levemir Novo Nordisk |
| Manufacturer | Novo Nordisk |
| Classification | Long-acting insulin analogue |
| Storage Requirements | 2-8°C, protect from light |
| Stability | Verify with supplier documentation |
| Purity | Pharmaceutical grade |
| Molecular Formula | Verify with supplier |
| CAS Number | Verify with supplier |
Research Use Compliance
This insulin analogue is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical use, or therapeutic applications. Researchers must ensure proper laboratory protocols, appropriate storage conditions, and compliance with institutional research guidelines when handling this compound. All studies should be conducted under appropriate laboratory supervision with proper safety measures and documentation.
